NEULAND LABORATORIES LTD. - 524558 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 about Loss of Share Certificate NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015 NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015 NEULAND LABORATORIES LTD. - 524558 - Disclosure On Related Party Transactions For Half Year Ended September 30, 2020
In terms of Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Disclosure on Related Party Transactions, on a consolidated basis for the half year ended September 30, 2020, drawn in accordance with applicable accounting standards. NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached herewith copies of the newspaper publication of Unaudited Financial Results for the quarter and half year ended September 30, 2020, published in Financial Express and Andhra Prabha on November 4, 2020 for your reference. This is for your information and records. 
Earnings Call for Q2FY21 of Neuland Laboratories
Conference Call with Neuland Laboratories Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript. NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation NEULAND LABORATORIES LTD. - 524558 - Corporate Action-Board approves Dividend
Corporate Action- Board approves Interim Dividend